Revolutionary Study Affirms NB-UVB Phototherapy's Role in Treating Multiple Sclerosis#USA#Multiple_Sclerosis#Cytokind#NB-UVB#Intervale
Revolutionary Study Affirms NB-UVB Phototherapy's Role in Treating Multiple Sclerosis
A recent study confirms that NB-UVB phototherapy significantly reduces inflammation in multiple sclerosis patients, highlighting its therapeutic potential beyond dermatological use.
third-news.com
October 28, 2025 at 5:17 PM
Revolutionary Study Affirms NB-UVB Phototherapy's Role in Treating Multiple Sclerosis#USA#Multiple_Sclerosis#Cytokind#NB-UVB#Intervale
Shaping Tomorrow Together: Empowering the Voices of Multiple Sclerosis Patients#USA#Washington#Multiple_Sclerosis#National_MS_Society#Shaping_Tomorrow
Shaping Tomorrow Together: Empowering the Voices of Multiple Sclerosis Patients
The initiative, Shaping Tomorrow Together, aims to elevate the insights of people living with multiple sclerosis to inform future treatments and therapies.
third-news.com
October 22, 2025 at 3:38 PM
Shaping Tomorrow Together: Empowering the Voices of Multiple Sclerosis Patients#USA#Washington#Multiple_Sclerosis#National_MS_Society#Shaping_Tomorrow
Noninvasive Brain Stimulation Device Shows Promise in Reducing Cannabis Addiction for MS Patients#United_States#New_York#Multiple_Sclerosis#Brain_Stimulation#Cannabis_Addiction
Noninvasive Brain Stimulation Device Shows Promise in Reducing Cannabis Addiction for MS Patients
A new study reveals that a noninvasive device may help individuals with multiple sclerosis reduce cannabis dependency, offering hope for effective treatment.
third-news.com
October 7, 2025 at 11:51 AM
Noninvasive Brain Stimulation Device Shows Promise in Reducing Cannabis Addiction for MS Patients#United_States#New_York#Multiple_Sclerosis#Brain_Stimulation#Cannabis_Addiction
Back from #ECTRIMS2025 in Barcelona! Where Claudia Rodriguez-Lopez masterfully presented our work “Progressive demyelination, neuroinflammation and disability by brain TAF1 alteration found in #multiple_sclerosis”, selected for Best of ECTRIMS Slide Deck!
@cbm-csic-uam.bsky.social
@uam.es @csic.es
@cbm-csic-uam.bsky.social
@uam.es @csic.es
September 30, 2025 at 5:33 PM
Back from #ECTRIMS2025 in Barcelona! Where Claudia Rodriguez-Lopez masterfully presented our work “Progressive demyelination, neuroinflammation and disability by brain TAF1 alteration found in #multiple_sclerosis”, selected for Best of ECTRIMS Slide Deck!
@cbm-csic-uam.bsky.social
@uam.es @csic.es
@cbm-csic-uam.bsky.social
@uam.es @csic.es
New Study Highlights Kesimpta® Efficacy in Relapsing MS Patients Switching from Oral Therapies#United_States#Multiple_Sclerosis#Novartis#East_Hanover#Kesimpta
New Study Highlights Kesimpta® Efficacy in Relapsing MS Patients Switching from Oral Therapies
Recent findings reveal that Kesimpta® shows remarkable effectiveness in treating relapsing multiple sclerosis, especially after switching from oral therapies.
third-news.com
September 24, 2025 at 6:53 AM
New Study Highlights Kesimpta® Efficacy in Relapsing MS Patients Switching from Oral Therapies#United_States#Multiple_Sclerosis#Novartis#East_Hanover#Kesimpta
Neuraxpharm Strengthens Commitment to Multiple Sclerosis at ECTRIMS 2025 in Barcelona#Spain#Barcelona#Multiple_Sclerosis#Neuraxpharm#ECTRIMS
Neuraxpharm Strengthens Commitment to Multiple Sclerosis at ECTRIMS 2025 in Barcelona
Neuraxpharm highlights its dedication to multiple sclerosis treatment at ECTRIMS 2025 in Barcelona, showcasing innovative therapies in CNS disorders.
third-news.com
September 22, 2025 at 2:54 PM
Neuraxpharm Strengthens Commitment to Multiple Sclerosis at ECTRIMS 2025 in Barcelona#Spain#Barcelona#Multiple_Sclerosis#Neuraxpharm#ECTRIMS
National Multiple Sclerosis Society Revolutionizes MS Diagnosis with Updated McDonald Criteria#United_States#New_York#Multiple_Sclerosis#MS_Society#McDonald_Criteria
National Multiple Sclerosis Society Revolutionizes MS Diagnosis with Updated McDonald Criteria
The National Multiple Sclerosis Society has updated the McDonald Diagnostic Criteria, streamlining the MS diagnosis process to enable quicker and more accurate results for patients.
third-news.com
September 18, 2025 at 4:09 PM
National Multiple Sclerosis Society Revolutionizes MS Diagnosis with Updated McDonald Criteria#United_States#New_York#Multiple_Sclerosis#MS_Society#McDonald_Criteria
Immunic's Patent Approval Marks Milestone for Vidofludimus Calcium in Multiple Sclerosis Treatment#United_States#New_York#Multiple_Sclerosis#Immunic#Vidofludimus
Immunic's Patent Approval Marks Milestone for Vidofludimus Calcium in Multiple Sclerosis Treatment
Immunic, Inc. has secured a U.S. patent for Vidofludimus Calcium, critical for treating progressive multiple sclerosis, offering significant market protection.
third-news.com
September 9, 2025 at 10:40 AM
Immunic's Patent Approval Marks Milestone for Vidofludimus Calcium in Multiple Sclerosis Treatment#United_States#New_York#Multiple_Sclerosis#Immunic#Vidofludimus
Immunic, Inc. Reveals Promising Second Quarter Results and Drug Advancements#USA#New_York#Multiple_Sclerosis#Immunic#Vidofludimus_Calcium
Immunic, Inc. Reveals Promising Second Quarter Results and Drug Advancements
Immunic, Inc. has reported significant clinical advancements and financial results for the second quarter of 2025, including updates on its lead drug, vidofludimus calcium.
third-news.com
August 7, 2025 at 10:45 AM
Immunic, Inc. Reveals Promising Second Quarter Results and Drug Advancements#USA#New_York#Multiple_Sclerosis#Immunic#Vidofludimus_Calcium
Explore Free Educational Resources from the Multiple Sclerosis Association of America#United_States#Multiple_Sclerosis#Cherry_Hill#MSAA#MSi_Video_Library
Explore Free Educational Resources from the Multiple Sclerosis Association of America
The Multiple Sclerosis Association of America offers free educational videos and webinars for those affected by MS. Discover valuable insights now.
third-news.com
June 25, 2025 at 4:37 PM
Explore Free Educational Resources from the Multiple Sclerosis Association of America#United_States#Multiple_Sclerosis#Cherry_Hill#MSAA#MSi_Video_Library
Immunic Presents Promising Long-Term Data on Vidofludimus Calcium for MS Patients at Phase 2 EMPhASIS Trial#USA#New_York#Multiple_Sclerosis#Immunic#Vidofludimus
Immunic Presents Promising Long-Term Data on Vidofludimus Calcium for MS Patients at Phase 2 EMPhASIS Trial
Immunic, Inc. has revealed new long-term data from the Phase 2 EMPhASIS trial for Vidofludimus Calcium, showcasing its efficacy in managing relapsing-remitting MS.
third-news.com
June 24, 2025 at 10:33 AM
Immunic Presents Promising Long-Term Data on Vidofludimus Calcium for MS Patients at Phase 2 EMPhASIS Trial#USA#New_York#Multiple_Sclerosis#Immunic#Vidofludimus
So proud of Claudia Rodríguez-López for her brilliant defense of her Doctoral Thesis entitled “TAF1-dependent transcriptional dysregulation underlies multiple sclerosis”
@cbm-csic-uam.bsky.social @csic.es
@felixhernandezp.bsky.social
#esclerosis_múltiple
#multiple_sclerosis
#ciberned
@cbm-csic-uam.bsky.social @csic.es
@felixhernandezp.bsky.social
#esclerosis_múltiple
#multiple_sclerosis
#ciberned
June 23, 2025 at 9:57 AM
So proud of Claudia Rodríguez-López for her brilliant defense of her Doctoral Thesis entitled “TAF1-dependent transcriptional dysregulation underlies multiple sclerosis”
@cbm-csic-uam.bsky.social @csic.es
@felixhernandezp.bsky.social
#esclerosis_múltiple
#multiple_sclerosis
#ciberned
@cbm-csic-uam.bsky.social @csic.es
@felixhernandezp.bsky.social
#esclerosis_múltiple
#multiple_sclerosis
#ciberned
Breakthrough Efficacy of Equecabtagene Autoleucel Presented at EAN Congress for MS Treatment#China#Shanghai#Multiple_Sclerosis#IASO_Bio#Equecabtagene
Breakthrough Efficacy of Equecabtagene Autoleucel Presented at EAN Congress for MS Treatment
At the 11th EAN Congress, IASO Bio showcased promising results from a study on Equecabtagene Autoleucel, an innovative MS therapy, indicating significant improvements in patient conditions.
third-news.com
June 23, 2025 at 2:07 AM
Breakthrough Efficacy of Equecabtagene Autoleucel Presented at EAN Congress for MS Treatment#China#Shanghai#Multiple_Sclerosis#IASO_Bio#Equecabtagene
Dog's Near-Fatal Encounter with Multiple Sclerosis Medication Highlights Pet Safety Concerns#United_States#Multiple_Sclerosis#Pet_Poison_Helpline#Cedar_Rapids#Kaya_the_Dog
Dog's Near-Fatal Encounter with Multiple Sclerosis Medication Highlights Pet Safety Concerns
A heartwarming yet alarming story reveals the near-fatal incident involving Kaya the dog, who mistakenly ingested a dangerous MS medication and overcame the odds with swift veterinary care.
third-news.com
June 18, 2025 at 2:52 PM
Dog's Near-Fatal Encounter with Multiple Sclerosis Medication Highlights Pet Safety Concerns#United_States#Multiple_Sclerosis#Pet_Poison_Helpline#Cedar_Rapids#Kaya_the_Dog
Rapid Growth of the Multiple Sclerosis Market Forecasted with a 3.8% CAGR from 2025 to 2034#None#Multiple_Sclerosis#DMTs#BTK_Inhibitors
Rapid Growth of the Multiple Sclerosis Market Forecasted with a 3.8% CAGR from 2025 to 2034
The Multiple Sclerosis market is projected to expand significantly, driven by advancements in treatment and increased prevalence, with a CAGR of 3.8% until 2034.
third-news.com
June 11, 2025 at 9:47 PM
Rapid Growth of the Multiple Sclerosis Market Forecasted with a 3.8% CAGR from 2025 to 2034#None#Multiple_Sclerosis#DMTs#BTK_Inhibitors
Immunic Completes Enrollment for Phase 3 Trials of Vidofludimus Calcium in Multiple Sclerosis#United_States#New_York#Multiple_Sclerosis#Immunic#Vidofludimus_Calcium
Immunic Completes Enrollment for Phase 3 Trials of Vidofludimus Calcium in Multiple Sclerosis
Immunic, a biotechnology firm, has concluded participant enrollment for its Phase 3 ENSURE trials exploring vidofludimus calcium in relapsing multiple sclerosis, signaling progress in treatment options.
third-news.com
June 5, 2025 at 10:43 AM
Immunic Completes Enrollment for Phase 3 Trials of Vidofludimus Calcium in Multiple Sclerosis#United_States#New_York#Multiple_Sclerosis#Immunic#Vidofludimus_Calcium
Join the 11th Improving Lives Benefit: A Celebration for the MS Community#USA#Philadelphia#Multiple_Sclerosis#Tyler_Campbell#Cionic
Join the 11th Improving Lives Benefit: A Celebration for the MS Community
The 11th Improving Lives Benefit hosted by MSAA aims to support the MS community through inspiring programs, auctions, and networking opportunities in Philadelphia.
third-news.com
April 24, 2025 at 2:40 PM
Join the 11th Improving Lives Benefit: A Celebration for the MS Community#USA#Philadelphia#Multiple_Sclerosis#Tyler_Campbell#Cionic
Biostate AI and Accelerated Cure Project Join Forces to Innovate MS Treatment with AI Models#United_States#Houston#Multiple_Sclerosis#Accelerated_Cure_Project#Biostate_AI
Biostate AI and Accelerated Cure Project Join Forces to Innovate MS Treatment with AI Models
Biostate AI has partnered with the Accelerated Cure Project to develop advanced AI models aimed at enhancing multiple sclerosis treatment, leveraging extensive RNA data.
third-news.com
April 17, 2025 at 2:08 PM
Biostate AI and Accelerated Cure Project Join Forces to Innovate MS Treatment with AI Models#United_States#Houston#Multiple_Sclerosis#Accelerated_Cure_Project#Biostate_AI
It’s my greatest pleasure to join the Bluesky community to broaden my network, to follow the pioneers and to communicate with peers.
#Multiple_sclerosis #neurology #MS #research #MRI #fMRI
#Multiple_sclerosis #neurology #MS #research #MRI #fMRI
March 26, 2025 at 8:33 PM
It’s my greatest pleasure to join the Bluesky community to broaden my network, to follow the pioneers and to communicate with peers.
#Multiple_sclerosis #neurology #MS #research #MRI #fMRI
#Multiple_sclerosis #neurology #MS #research #MRI #fMRI
Accelerated Cure Project Unveils AI Resource for MS Caregivers Available Around the Clock#United_States#Multiple_Sclerosis#Waltham#Accelerated_Cure_Project#AI_Caregiving_Expert
Accelerated Cure Project Unveils AI Resource for MS Caregivers Available Around the Clock
Accelerated Cure Project has launched a transformative AI tool for caregivers of MS patients, providing reliable answers 24/7 to support their needs.
third-news.com
March 12, 2025 at 1:55 PM
Accelerated Cure Project Unveils AI Resource for MS Caregivers Available Around the Clock#United_States#Multiple_Sclerosis#Waltham#Accelerated_Cure_Project#AI_Caregiving_Expert
Community Comes Together for Fun and Philanthropy at Kalfus & Nachman's MS Fundraiser#United_States#Multiple_Sclerosis#Norfolk#Fundraiser#Kalfus_Nachman
Community Comes Together for Fun and Philanthropy at Kalfus & Nachman's MS Fundraiser
Join Kalfus & Nachman on March 28, 2025, as they host a unique fundraising event in Norfolk, VA, supporting Multiple Sclerosis research and advocacy.
third-news.com
March 11, 2025 at 2:56 PM
Community Comes Together for Fun and Philanthropy at Kalfus & Nachman's MS Fundraiser#United_States#Multiple_Sclerosis#Norfolk#Fundraiser#Kalfus_Nachman
National MS Society Introduces New Campaign to Promote Awareness and Support During MS Awareness Week#United_States#New_York#Multiple_Sclerosis#MS_Awareness#National_MS_Society
National MS Society Introduces New Campaign to Promote Awareness and Support During MS Awareness Week
The National Multiple Sclerosis Society launches the impactful 'Tell MS It Ends With Us' campaign during MS Awareness Week to engage and educate.
third-news.com
March 5, 2025 at 1:34 PM
National MS Society Introduces New Campaign to Promote Awareness and Support During MS Awareness Week#United_States#New_York#Multiple_Sclerosis#MS_Awareness#National_MS_Society
New Treatment Approach Aims to Close Gap for MS Patients of Color#USA#San_Diego#Multiple_Sclerosis#Health_Disparities#treatment_algorithm
New Treatment Approach Aims to Close Gap for MS Patients of Color
A pioneering algorithm may significantly reduce treatment disparities faced by Hispanic and Black individuals with multiple sclerosis by guiding effective treatment options.
third-news.com
March 3, 2025 at 10:51 PM
New Treatment Approach Aims to Close Gap for MS Patients of Color#USA#San_Diego#Multiple_Sclerosis#Health_Disparities#treatment_algorithm
Empowering the MS Community: March Recognized as MS Awareness Month by MSAA#United_States#Multiple_Sclerosis#Cherry_Hill#MSAA#MS_Awareness
Empowering the MS Community: March Recognized as MS Awareness Month by MSAA
During March, the Multiple Sclerosis Association of America presents initiatives to empower those diagnosed with MS, focusing on self-advocacy and support.
third-news.com
March 3, 2025 at 2:59 PM
Empowering the MS Community: March Recognized as MS Awareness Month by MSAA#United_States#Multiple_Sclerosis#Cherry_Hill#MSAA#MS_Awareness
Immunic Showcases Vidofludimus Calcium Research at ACTRIMS 2025 Forum#United_States#Multiple_Sclerosis#West_Palm_Beach#Immunic#Vidofludimus_Calcium
Immunic Showcases Vidofludimus Calcium Research at ACTRIMS 2025 Forum
Immunic, Inc. unveiled detailed findings on Vidofludimus Calcium at the ACTRIMS Forum 2025, offering hope for multiple sclerosis treatments.
third-news.com
February 26, 2025 at 11:39 AM
Immunic Showcases Vidofludimus Calcium Research at ACTRIMS 2025 Forum#United_States#Multiple_Sclerosis#West_Palm_Beach#Immunic#Vidofludimus_Calcium